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Because of their high cell selectivity and potent cell killing efficacv immunotoxins (ITs) could be ven useful in eradicating microaggregates of tumour cells escaping conventional therapies and as an adjuvant treatment for the prevention of tumour relapse (Vitetta et al.. 1993) . The cytoreductive potential of chemo-or radiotherapeutic agents against tumour masses has been evaluated in a number of experimental models during the past several years (Vitetta et al.. 1993) . However. little information is available on the direct effects of ITs on tumour cell aggregates. in which factors resulting from the three-dimensional organisation of tumour cells (e.g. antigen site barrier. heterogeneous target antigen distribution. elevated interstitial pressure) may contribute to limit the efficacy of an IT-based immunotherapy (Sutherland. 1988: Weinstein and van Osdol. 1992 (Sutherland. 1988 (Demicheli et al.. 1989) . MTSs have been extensively used for studies of chemotherapy and radiation therapy (Sutherland. 1988: Rofstad and Sutherland. 1989) . Moreover. MTSs are amenable to investigations on the binding and penetration of MAb and ITs into three-dimensional masses (Kwok et al.. 1988; Chen et al.. 1991 : Kikuchi et al.. 1992 . Recently. poor and inhomogeneous penetration of an anti-melanoma IT within MTSs has been reported (Kikuchi et al.. 1992) : this correlated with a lower activity of the ITs against MTSs than against cell monolayers. Using a similar approach we found that the potency of anti-TfnR IT or toxin against MTSs is greatly influenced by the number of target antigens and by the strength of the IT toxin-cell interaction (Chignola et al.. 1994b) . In those studies. however. the sensitivitx to treatment of individual three-dimensional tumour cell aggregates was not investigated. In vivo tumour relapse is often due to the regrowth of micromasses escaping therapy. To establish patterns of response to treatment of single micromasses has obvious therapeutic implications. 
where V(t) is the volume of the spheroid at time t, V (0) Lloyd, 1975; Demicheli et al., 1989) . The parameter ato can be calculated using the following formula, which is obtainable from the Gompertz growth equation (Demicheli et al., 1989) :
V0 where ao, Fb' P and V(O) are as already defined and VO is the volume of a single cell (assumed to be 10-6mm3; see also Demicheli et al., 1989) .
The cytoreductive effects of anti-TfnR IT and of ricin toxin on MTSs could be measured only in those spheroids which displayed a measurable regrowth curve following a delay. Experimental data of volume increase vs time were fitted with the Gompertz growth equation and suitable regrowth curves were extrapolated backwards to the time immediately after treatment (0 days, see Figure 1 ). The corresponding ordinate was taken as the volume of the spheroid after a given treatment (Vr,) (Demicheli et al., 1988; Chignola et al., 1994b Figure 2c and d). The two patterns of response to IT treatment as shown in Figure 2 were observed for all the ITs assayed and for ricin toxin on both MCF7 and 9L MTSs. The results are summarised in Figure 3 (Figure 4) . 
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We therefore considered the doubling time (TD) as a marker of the proliferative potential of surviving cells.
Information on MTS growth below V_ can be obtained by applying the following formula correlating the fraction of surviving cells F (see also Materials and methods) with the Igrowth delay'. GD (i.e. the time during which a treated MTS does not show a measurable regrowth; see also Figure  1 ) measured for the treated non-sterilised MTS. The result of this correlation is the doubling time TD of the surviving cells (Twentyman, 1980) :
The above equation is valid if the doubling time of regrowmg cells in the treated non-stenlised MTS remains constant (i.e. exponential growth). This constraint applies to our data because MTSs were treated below the critical volume at which the transition between the exponential and the Gompertzian growth is expected to occur. According to Demicheli et al. (1989) . this critical volume can be calculated on the basis of the linear correlation between ao and f and turned out to be 16.9 x 10-mm" and 45.4 x 10-3 mm" for MCF7 and 9L MTS respectively.
We therefore plotted the measured growth delay vs -log (surviving fraction for example Figure 9 for F= 1O-'. TD = 15, 19. 24 and 36 h).
As a consequence. treated non-sterilised MTSs regrew following individual growth patterns until their volumes approached ',.
In addition. from Figures 8 and 9 . a clear-cut pattern of behaviour could be discerned (see boxed-in areas): MTSs in which IT treatment resulted in a considerable cell death regrew with short TD (for F<0.02 TD+ s.d. = 24.11 ± 5.78 h and 15.44 ± 2.82 h for MCF7 and 9L MTS respectively): converselv, when IT treatment had a smaller effect, TD was somewhat longer (for 0.02 < F< 1 TD ± s.d. = 45.45 ± 14.68 h and 24.05 ± 7.07 h for MCF7 and 9L MTS respectively).
Growth delay (days) The present study demonstrates that: (1) Twentyman, 1980; Rofstad and Sutherland, 1989: Kikuchi et al., 1992) . Using this method, however, the surviving fraction could be greatly underestimated owing to the cell-damaging effect of the disaggregation procedure (Twentyman. 1980). Moreover, in clonogenic assays the role played by the three-dimensional organisation of tumour cells on the post-treatment growing potential of the tumour micromasses cannot be evaluated. Alternative ways of evaluating the effects induced by a treatment on three-dimensional tumour cell aggregates also include the measurement of the 'growth delay'. However, the evaluation of IT cytoreductive effects on the basis of the 'growth delay' only could be misleading. In fact, the 'growth delay' is strictly dependent on the individual post-treatment regrowth kinetics of each MTS. That is, if a spheroid regrows slowly, its 'growth delay' will appear longer than that of another spheroid which has a faster regrowth but whose cell number has been reduced to the same extent by the treatment. On the other hand, calculations of log kill based on the Gompertz growth model are acceptable because the assumptions listed in Material and methods are valid in our experimental set-up. We believe that this is indeed the case because the ITs are endowed with biological and phar- 
